Literature DB >> 22212812

ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury.

Masayuki Fujioka1, Takafumi Nakano, Kazuhide Hayakawa, Keiichi Irie, Yoshiharu Akitake, Yuya Sakamoto, Kenichi Mishima, Carl Muroi, Yasuhiro Yonekawa, Fumiaki Banno, Koichi Kokame, Toshiyuki Miyata, Kenji Nishio, Kazuo Okuchi, Katsunori Iwasaki, Michihiro Fujiwara, Bo K Siesjö.   

Abstract

Highly adhesive glycoprotein von Willebrand factor (VWF) multimer induces platelet aggregation and leukocyte tethering or extravasation on the injured vascular wall, contributing to microvascular plugging and inflammation in brain ischemia-reperfusion. A disintegrin and metalloproteinase with thrombospondin type-1 motifs 13 (ADAMTS13) cleaves the VWF multimer strand and reduces its prothrombotic and proinflammatory functions. Although ADAMTS13 deficiency is known to amplify post-ischemic cerebral hypoperfusion, there is no report available on the effect of ADAMTS13 on inflammation after brain ischemia. We investigated if ADAMTS13 deficiency intensifies the increase of extracellular HMGB1, a hallmark of post-stroke inflammation, and exacerbates brain injury after ischemia-reperfusion. ADAMTS13 gene knockout (KO) and wild-type (WT) mice were subjected to 30-min middle cerebral artery occlusion (MCAO) and 23.5-h reperfusion under continuous monitoring of regional cerebral blood flow (rCBF). The infarct volume, plasma high-mobility group box1 (HMGB1) level, and immunoreactivity of the ischemic cerebral cortical tissue (double immunofluorescent labeling) against HMGB1/NeuN (neuron-specific nuclear protein) or HMGB1/MPO (myeloperoxidase) were estimated 24 h after MCAO. ADAMTS13KO mice had larger brain infarcts compared with WT 24 h after MCAO (p < 0.05). The rCBF during reperfusion decreased more in ADAMTS13KO mice. The plasma HMGB1 increased more in ADAMTS13KO mice than in WT after ischemia-reperfusion (p < 0.05). Brain ischemia induced more prominent activation of inflammatory cells co-expressing HMGB1 and MPO and more marked neuronal death in the cortical ischemic penumbra of ADAMTS13KO mice. ADAMTS13 deficiency may enhance systemic and brain inflammation associated with HMGB1 neurotoxicity, and aggravate brain damage in mice after brief focal ischemia. We hypothesize that ADAMTS13 protects brain from ischemia-reperfusion injury by regulating VWF-dependent inflammation as well as microvascular plugging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22212812     DOI: 10.1007/s10072-011-0913-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  48 in total

1.  Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia.

Authors:  T Abumiya; R Fitridge; C Mazur; B R Copeland; J A Koziol; J F Tschopp; M D Pierschbacher; G J del Zoppo
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

2.  Shear-dependent changes in the three-dimensional structure of human von Willebrand factor.

Authors:  C A Siedlecki; B J Lestini; K K Kottke-Marchant; S J Eppell; D L Wilson; R E Marchant
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

3.  HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain.

Authors:  Jung-Bin Kim; Joon Sig Choi; Young-Mi Yu; Kihoon Nam; Chun-Shu Piao; Seung-Woo Kim; Min-Hyung Lee; Pyung-Lim Han; Jong-Sang Park; Ja-Kyeong Lee
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

Review 4.  von Willebrand factor, endothelial dysfunction, and cardiovascular disease.

Authors:  U M Vischer
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

5.  Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration.

Authors:  Masayuki Fujioka; Toshiaki Taoka; Yoshiyuki Matsuo; Kenichi Mishima; Kumiko Ogoshi; Yoichi Kondo; Masakazu Tsuda; Michihiro Fujiwara; Takao Asano; Toshisuke Sakaki; Akihiro Miyasaki; Darren Park; Bo K Siesjö
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

6.  Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism.

Authors:  Kazuhide Hayakawa; Kenichi Mishima; Keiichi Irie; Mai Hazekawa; Shohei Mishima; Masayuki Fujioka; Kensuke Orito; Nobuaki Egashira; Shutaro Katsurabayashi; Kotaro Takasaki; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  Neuropharmacology       Date:  2008-06-27       Impact factor: 5.250

7.  von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.

Authors:  Bing-Qiao Zhao; Anil K Chauhan; Matthias Canault; Ian S Patten; Janie J Yang; Michael Dockal; Friedrich Scheiflinger; Denisa D Wagner
Journal:  Blood       Date:  2009-08-17       Impact factor: 22.113

8.  Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons.

Authors:  G J del Zoppo; G W Schmid-Schönbein; E Mori; B R Copeland; C M Chang
Journal:  Stroke       Date:  1991-10       Impact factor: 7.914

9.  The HMGB1 receptor RAGE mediates ischemic brain damage.

Authors:  Sajjad Muhammad; Waleed Barakat; Stoyan Stoyanov; Sasidhar Murikinati; Huan Yang; Kevin J Tracey; Martin Bendszus; Grazisa Rossetti; Peter P Nawroth; Angelika Bierhaus; Markus Schwaninger
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

10.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  17 in total

1.  ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis.

Authors:  Astrid Alflen; Steve Prüfer; Katharina Ebner; Sebastian Reuter; Pamela Aranda Lopez; Inge Scharrer; Fumiaki Banno; Michael Stassen; Hansjörg Schild; Kerstin Jurk; Markus Bosmann; Hendrik Beckert; Markus P Radsak
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

2.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

Review 3.  Structure-function and regulation of ADAMTS-13 protease.

Authors:  X L Zheng
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 4.  Platelets as drivers of ischemia/reperfusion injury after stroke.

Authors:  Noor F Shaik; Raymond F Regan; Ulhas P Naik
Journal:  Blood Adv       Date:  2021-03-09

5.  ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice.

Authors:  M M Khan; D G Motto; S R Lentz; A K Chauhan
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

6.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

7.  miR-525-5p inhibits ADAMTS13 and is correlated with Ischemia/reperfusion injury-induced neuronal cell death.

Authors:  Liyan Zhao; Cong Hua; Yunqian Li; Qingqing Sun; Wei Wu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice.

Authors:  Chintan Gandhi; David G Motto; Melissa Jensen; Steven R Lentz; Anil K Chauhan
Journal:  Blood       Date:  2012-09-14       Impact factor: 22.113

Review 9.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

10.  Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis.

Authors:  Edvin Ingberg; Hua Dock; Elvar Theodorsson; Annette Theodorsson; Jakob O Ström
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.